Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX

Clinical trial NCT01396707 · COMPLETED

Trial details

NCT number: NCT01396707
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic or Recurrent Gastric Adenocarcinoma Her-2 Positive Gastric Cancer

Start date: 2011-06-01
Primary completion: 2018-11-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.